Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are based in China and have been diagnosed with moderately to severely active Ulcerative Colitis (UC), a condition causing inflammation in the large intestine
- People whose treating doctor has decided to prescribe a medication called upadacitinib, based on their own assessment of the benefits and risks for that person according to the approved local guidelines
- People who are 18 years of age or older
- People who have provided written consent allowing their personal and health information to be used before entering the study
Who may not be able to join:
- People who are already taking part in another clinical trial that involves a treatment or intervention
- People who have a medical reason that makes taking upadacitinib unsafe or unsuitable, as listed in the official China medication guidelines for this drug
- People who are unwilling or unable to follow the study requirements, including filling out questionnaires about their health and symptoms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Achievement of clinical response per partial adapted Mayo score.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.